Please wait while we load the requested 10-Q report or click the link below:
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019
~ Strong year-over-year growth in revenue, net income, and earnings per share ~
~ Growth balanced across the entire product portfolio ~
Note: A webcast of ResMeds conference call will be available at 4:30 p.m. EDT today at http://investor.resmed.com
SAN DIEGO, October 25, 2018 ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended September 30, 2018.
First Quarter 2019 Highlights
Revenue increased 12% to $588.3 million; up 13% on a constant currency basis
Net income increased by 23%; non-GAAP net income up 23%
GAAP diluted earnings per share of $0.73; non-GAAP diluted earnings per share of $0.81
Our first quarter 2019 results demonstrate continued strong performance across our business with 13 percent top-line revenue growth, driven by growth across our entire portfolio of offerings, said Mick Farrell, ResMeds chief executive officer. We also delivered another quarter of improving operating leverage resulting in double-digit growth at the bottom line.
Farrell continued, During the quarter we expanded our product portfolio with new masks and made ongoing upgrades to our digital health solutions, separating ResMed from the competition. We provide customers with services and solutions to help improve patient outcomes, create efficiencies, and reduce overall healthcare system costs.
The following information was filed by Resmed Inc (RMD) on Thursday, October 25, 2018 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Resmed Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were
removed , and by Resmed Inc.